Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: Singapore Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20153
20174
20193
20203
20216
20227
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Novartis Pharmaceuticals5
AstraZeneca3
Eli Lilly and Company3
National Cancer Centre, Singapore2
Pfizer2
ArriVent BioPharma, Inc.1
Bayer1
BeiGene1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung32
Colorectal Neoplasms5
Lung Neoplasms5
Melanoma4
Neoplasm Metastasis4
Colonic Neoplasms3
Head and Neck Neoplasms3
Lung Diseases3
Neoplasms3
Ovarian Neoplasms3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.